ID   M4K2_HUMAN              Reviewed;         820 AA.
AC   Q12851;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   19-MAR-2014, entry version 134.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 2;
DE            EC=2.7.11.1;
DE   AltName: Full=B lymphocyte serine/threonine-protein kinase;
DE   AltName: Full=Germinal center kinase;
DE            Short=GC kinase;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 2;
DE            Short=MEK kinase kinase 2;
DE            Short=MEKKK 2;
DE   AltName: Full=Rab8-interacting protein;
GN   Name=MAP4K2; Synonyms=GCK, RAB8IP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-820, FUNCTION, DOMAIN, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Tonsil;
RX   PubMed=7515885;
RA   Katz P., Whalen G., Kehrl J.H.;
RT   "Differential expression of a novel protein kinase in human B
RT   lymphocytes. Preferential localization in the germinal center.";
RL   J. Biol. Chem. 269:16802-16809(1994).
RN   [3]
RP   FUNCTION, AND ENZYME REGULATION.
RX   PubMed=7477268; DOI=10.1038/377750a0;
RA   Pombo C.M., Kehrl J.H., Sanchez I., Katz P., Avruch J., Zon L.I.,
RA   Woodgett J.R., Force T., Kyriakis J.M.;
RT   "Activation of the SAPK pathway by the human STE20 homologue germinal
RT   centre kinase.";
RL   Nature 377:750-754(1995).
RN   [4]
RP   FUNCTION, AUTOPHOSPHORYLATION, AND INTERACTION WITH MAP3K1/MEKK1 AND
RP   TRAF2.
RX   PubMed=9712898; DOI=10.1074/jbc.273.35.22681;
RA   Yuasa T., Ohno S., Kehrl J.H., Kyriakis J.M.;
RT   "Tumor necrosis factor signaling to stress-activated protein kinase
RT   (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase
RT   couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1
RT   and SAPK while receptor interacting protein associates with a mitogen-
RT   activated protein kinase kinase kinase upstream of MKK6 and p38.";
RL   J. Biol. Chem. 273:22681-22692(1998).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH TRAF2 AND MAP3K1.
RX   PubMed=11784851; DOI=10.1128/MCB.22.3.737-749.2002;
RA   Chadee D.N., Yuasa T., Kyriakis J.M.;
RT   "Direct activation of mitogen-activated protein kinase kinase kinase
RT   MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2.";
RL   Mol. Cell. Biol. 22:737-749(2002).
RN   [6]
RP   ENZYME REGULATION, FUNCTION, UBIQUITINATION, AND INTERACTION WITH
RP   TRAF6.
RX   PubMed=15456887; DOI=10.1128/MCB.24.20.9165-9175.2004;
RA   Zhong J., Kyriakis J.M.;
RT   "Germinal center kinase is required for optimal Jun N-terminal kinase
RT   activation by Toll-like receptor agonists and is regulated by the
RT   ubiquitin proteasome system and agonist-induced, TRAF6-dependent
RT   stabilization.";
RL   Mol. Cell. Biol. 24:9165-9175(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH MAP3K11/MLK3.
RX   PubMed=17584736; DOI=10.1074/jbc.M703422200;
RA   Zhong J., Kyriakis J.M.;
RT   "Dissection of a signaling pathway by which pathogen-associated
RT   molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine
RT   release.";
RL   J. Biol. Chem. 282:24246-24254(2007).
RN   [8]
RP   REVIEW ON FUNCTION.
RX   PubMed=10026130; DOI=10.1074/jbc.274.9.5259;
RA   Kyriakis J.M.;
RT   "Signaling by the germinal center kinase family of protein kinases.";
RL   J. Biol. Chem. 274:5259-5262(1999).
RN   [9]
RP   REVIEW ON FUNCTION.
RX   PubMed=11316611; DOI=10.1016/S0962-8924(01)01980-8;
RA   Dan I., Watanabe N.M., Kusumi A.;
RT   "The Ste20 group kinases as regulators of MAP kinase cascades.";
RL   Trends Cell Biol. 11:220-230(2001).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Serine/threonine-protein kinase which acts as an
CC       essential component of the MAP kinase signal transduction pathway.
CC       Acts as a MAPK kinase kinase kinase (MAP4K) and is an upstream
CC       activator of the stress-activated protein kinase/c-Jun N-terminal
CC       kinase (SAP/JNK) signaling pathway and to a lesser extend of the
CC       p38 MAPKs signaling pathway. Required for the efficient activation
CC       of JNKs by TRAF6-dependent stimuli, including pathogen-associated
CC       molecular patterns (PAMPs) such as polyinosine-polycytidine
CC       (poly(IC)), lipopolysaccharides (LPS), lipid A, peptidoglycan
CC       (PGN), or bacterial flagellin. To a lesser degree, IL-1 and
CC       engagement of CD40 also stimulate MAP4K2-mediated JNKs activation.
CC       The requirement for MAP4K2/GCK is most pronounced for LPS
CC       signaling, and extends to LPS stimulation of c-Jun phosphorylation
CC       and induction of IL-8. Enhances MAP3K1 oligomerization, which may
CC       relieve N-terminal mediated MAP3K1 autoinhibition and lead to
CC       activation following autophosphorylation. Mediates also the
CC       SAP/JNK signaling pathway and the p38 MAPKs signaling pathway
CC       through activation of the MAP3Ks MAP3K10/MLK2 and MAP3K11/MLK3.
CC       May play a role in the regulation of vesicle targeting or fusion.
CC       regulation of vesicle targeting or fusion.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: The tumor necrosis factor (TNF), as well as
CC       endotoxins and proinflammatory stimuli such as polyinosine-
CC       polycytidine (poly(IC)), lipopolysaccharides (LPS), peptidoglycan
CC       (PGN), flagellin, or lipid A activate MAP4K2 by promoting its
CC       autophosphorylation.
CC   -!- SUBUNIT: Interacts with TRAF2, TRAF6, MAP3K1/MEKK1 and
CC       MAP3K11/MLK3. Interacts with RAB8A (By similarity).
CC   -!- INTERACTION:
CC       Q13233:MAP3K1; NbExp=2; IntAct=EBI-49783, EBI-49776;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Basolateral cell
CC       membrane; Peripheral membrane protein (By similarity). Golgi
CC       apparatus membrane; Peripheral membrane protein (By similarity).
CC   -!- TISSUE SPECIFICITY: Highly expressed in germinal center but not
CC       mantle zone B-cells. Also expressed in lung, brain and placenta
CC       and at lower levels in other tissues examined.
CC   -!- DOMAIN: The PEST domains are Pro-, Glu-, Ser-, and Thr-rich
CC       domains. Proteins with PEST domains are frequently targets of
CC       degradation by the ubiquitin proteasome.
CC   -!- PTM: Polyubiquitinated through 'Lys-48'-polyubiquitin chains,
CC       allowing proteasomal turnover. Ubiquitination requires the kinase
CC       activity of MAP4K2/GCK.
CC   -!- PTM: Autophosphorylated in response to tumor necrosis factor
CC       (TNF), endotoxins or proinflammatory stimuli. Autophosphorylation
CC       leads to activation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 CNH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA20968.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001462; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U07349; AAA20968.1; ALT_SEQ; mRNA.
DR   PIR; A53714; A53714.
DR   RefSeq; NP_004570.2; NM_004579.3.
DR   UniGene; Hs.534341; -.
DR   ProteinModelPortal; Q12851; -.
DR   SMR; Q12851; 10-389.
DR   BioGrid; 111809; 16.
DR   IntAct; Q12851; 11.
DR   MINT; MINT-8247528; -.
DR   STRING; 9606.ENSP00000294066; -.
DR   BindingDB; Q12851; -.
DR   ChEMBL; CHEMBL5330; -.
DR   GuidetoPHARMACOLOGY; 2086; -.
DR   PhosphoSite; Q12851; -.
DR   DMDM; 215274019; -.
DR   PaxDb; Q12851; -.
DR   PRIDE; Q12851; -.
DR   DNASU; 5871; -.
DR   Ensembl; ENST00000294066; ENSP00000294066; ENSG00000168067.
DR   GeneID; 5871; -.
DR   KEGG; hsa:5871; -.
DR   UCSC; uc001obh.3; human.
DR   CTD; 5871; -.
DR   GeneCards; GC11M064556; -.
DR   H-InvDB; HIX0026186; -.
DR   HGNC; HGNC:6864; MAP4K2.
DR   HPA; HPA007330; -.
DR   MIM; 603166; gene.
DR   neXtProt; NX_Q12851; -.
DR   PharmGKB; PA30610; -.
DR   eggNOG; COG0515; -.
DR   HOGENOM; HOG000230824; -.
DR   HOVERGEN; HBG036702; -.
DR   InParanoid; Q12851; -.
DR   KO; K04414; -.
DR   OMA; EIYHATG; -.
DR   PhylomeDB; Q12851; -.
DR   TreeFam; TF105121; -.
DR   SignaLink; Q12851; -.
DR   GeneWiki; MAP4K2; -.
DR   GenomeRNAi; 5871; -.
DR   NextBio; 22804; -.
DR   PRO; PR:Q12851; -.
DR   ArrayExpress; Q12851; -.
DR   Bgee; Q12851; -.
DR   CleanEx; HS_GCK; -.
DR   CleanEx; HS_MAP4K2; -.
DR   Genevestigator; Q12851; -.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IBA:RefGenome.
DR   GO; GO:0005083; F:small GTPase regulator activity; IEA:InterPro.
DR   GO; GO:0007257; P:activation of JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0006903; P:vesicle targeting; IEA:Ensembl.
DR   InterPro; IPR001180; Citron.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase_dom.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Complete proteome; Cytoplasm;
KW   Golgi apparatus; Immunity; Innate immunity; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Stress response; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    820       Mitogen-activated protein kinase kinase
FT                                kinase kinase 2.
FT                                /FTId=PRO_0000086275.
FT   DOMAIN       16    273       Protein kinase.
FT   DOMAIN      482    793       CNH.
FT   NP_BIND      22     30       ATP (By similarity).
FT   REGION      294    314       PEST1.
FT   REGION      344    360       PEST2.
FT   REGION      405    448       PEST3.
FT   ACT_SITE    136    136       Proton acceptor (By similarity).
FT   BINDING      45     45       ATP (By similarity).
FT   MOD_RES     394    394       Phosphoserine.
FT   CONFLICT    120    120       A -> R (in Ref. 2; AAA20968).
SQ   SEQUENCE   820 AA;  91556 MW;  A59C1E99BFFAEF41 CRC64;
     MALLRDVSLQ DPRDRFELLQ RVGAGTYGDV YKARDTVTSE LAAVKIVKLD PGDDISSLQQ
     EITILRECRH PNVVAYIGSY LRNDRLWICM EFCGGGSLQE IYHATGPLEE RQIAYVCREA
     LKGLHHLHSQ GKIHRDIKGA NLLLTLQGDV KLADFGVSGE LTASVAKRRS FIGTPYWMAP
     EVAAVERKGG YNELCDVWAL GITAIELGEL QPPLFHLHPM RALMLMSKSS FQPPKLRDKT
     RWTQNFHHFL KLALTKNPKK RPTAEKLLQH PFTTQQLPRA LLTQLLDKAS DPHLGTPSPE
     DCELETYDMF PDTIHSRGQH GPAERTPSEI QFHQVKFGAP RRKETDPLNE PWEEEWTLLG
     KEELSGSLLQ SVQEALEERS LTIRSASEFQ ELDSPDDTMG TIKRAPFLGP LPTDPPAEEP
     LSSPPGTLPP PPSGPNSSPL LPTAWATMKQ REDPERSSCH GLPPTPKVHM GACFSKVFNG
     CPLRIHAAVT WIHPVTRDQF LVVGAEEGIY TLNLHELHED TLEKLISHRC SWLYCVNNVL
     LSLSGKSTHI WAHDLPGLFE QRRLQQQVPL SIPTNRLTQR IIPRRFALST KIPDTKGCLQ
     CRVVRNPYTG ATFLLAALPT SLLLLQWYEP LQKFLLLKNF SSPLPSPAGM LEPLVLDGKE
     LPQVCVGAEG PEGPGCRVLF HVLPLEAGLT PDILIPPEGI PGSAQQVIQV DRDTILVSFE
     RCVRIVNMQG EPTATLAPEL TFDFPIETVV CLQDSVLAFW SHGMQGRSLD TNEVTQEITD
     ETRIFRVLGA HRDIILESIP TDNPEAHSNL YILTGHQSTY
//
ID   MP2K4_MOUSE             Reviewed;         397 AA.
AC   P47809;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   19-MAR-2014, entry version 118.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 4;
DE            Short=MAP kinase kinase 4;
DE            Short=MAPKK 4;
DE            EC=2.7.12.2;
DE   AltName: Full=C-JUN N-terminal kinase kinase 1;
DE            Short=JNK kinase 1;
DE            Short=JNKK 1;
DE   AltName: Full=JNK-activating kinase 1;
DE   AltName: Full=MAPK/ERK kinase 4;
DE            Short=MEK 4;
DE   AltName: Full=SAPK/ERK kinase 1;
DE            Short=SEK1;
GN   Name=Map2k4; Synonyms=Jnkk1, Mek4, Mkk4, Prkmk4, Sek1, Serk1, Skk1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND MUTAGENESIS OF LYS-129.
RC   TISSUE=Embryo;
RX   PubMed=7997269; DOI=10.1038/372794a0;
RA   Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J.,
RA   Kyriakis J.M., Zon L.I.;
RT   "Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating
RT   transcription factor c-Jun.";
RL   Nature 372:794-798(1994).
RN   [2]
RP   SEQUENCE REVISION.
RA   Zon L.I.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION.
RX   PubMed=9620683; DOI=10.1016/S1074-7613(00)80567-1;
RA   Swat W., Fujikawa K., Ganiatsas S., Yang D., Xavier R.J., Harris N.L.,
RA   Davidson L., Ferrini R., Davis R.J., Labow M.A., Flavell R.A.,
RA   Zon L.I., Alt F.W.;
RT   "SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid
RT   compartment but not for lymphocyte development.";
RL   Immunity 8:625-634(1998).
RN   [4]
RP   ENZYME REGULATION, SUBCELLULAR LOCATION, AND FUNCTION OF THE MKK/JNK
RP   PATHWAY.
RX   PubMed=9891090;
RA   Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J.;
RT   "The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.";
RL   Mol. Cell. Biol. 19:1569-1581(1999).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=10095085; DOI=10.1016/S0169-328X(99)00035-2;
RA   Lee J.K., Hwang W.S., Lee Y.D., Han P.L.;
RT   "Dynamic expression of SEK1 suggests multiple roles of the gene during
RT   embryogenesis and in adult brain of mice.";
RL   Brain Res. Mol. Brain Res. 66:133-140(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=11390361; DOI=10.1101/gad.888501;
RA   Tournier C., Dong C., Turner T.K., Jones S.N., Flavell R.A.,
RA   Davis R.J.;
RT   "MKK7 is an essential component of the JNK signal transduction pathway
RT   activated by proinflammatory cytokines.";
RL   Genes Dev. 15:1419-1426(2001).
RN   [7]
RP   PHOSPHORYLATION, AND INTERACTION WITH MAP3K1/MEKK1.
RX   PubMed=12401521; DOI=10.1016/S0898-6568(02)00056-6;
RA   Tu Z., Mooney S.M., Lee F.S.;
RT   "A subdomain of MEKK1 that is critical for binding to MKK4.";
RL   Cell. Signal. 15:65-77(2003).
RN   [8]
RP   FUNCTION.
RX   PubMed=12624093; DOI=10.1074/jbc.M213182200;
RA   Kishimoto H., Nakagawa K., Watanabe T., Kitagawa D., Momose H.,
RA   Seo J., Nishitai G., Shimizu N., Ohata S., Tanemura S., Asaka S.,
RA   Goto T., Fukushi H., Yoshida H., Suzuki A., Sasaki T., Wada T.,
RA   Penninger J.M., Nishina H., Katada T.;
RT   "Different properties of SEK1 and MKK7 in dual phosphorylation of
RT   stress-induced activated protein kinase SAPK/JNK in embryonic stem
RT   cells.";
RL   J. Biol. Chem. 278:16595-16601(2003).
RN   [9]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=17875933; DOI=10.1128/MCB.00226-07;
RA   Wang X., Nadarajah B., Robinson A.C., McColl B.W., Jin J.W.,
RA   Dajas-Bailador F., Boot-Handford R.P., Tournier C.;
RT   "Targeted deletion of the mitogen-activated protein kinase kinase 4
RT   gene in the nervous system causes severe brain developmental defects
RT   and premature death.";
RL   Mol. Cell. Biol. 27:7935-7946(2007).
RN   [10]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19265040; DOI=10.1161/CIRCRESAHA.108.188292;
RA   Liu W., Zi M., Jin J., Prehar S., Oceandy D., Kimura T.E., Lei M.,
RA   Neyses L., Weston A.H., Cartwright E.J., Wang X.;
RT   "Cardiac-specific deletion of mkk4 reveals its role in pathological
RT   hypertrophic remodeling but not in physiological cardiac growth.";
RL   Circ. Res. 104:905-914(2009).
RN   [11]
RP   REVIEW ON ENZYME REGULATION.
RX   PubMed=17496909; DOI=10.1038/sj.onc.1210392;
RA   Raman M., Chen W., Cobb M.H.;
RT   "Differential regulation and properties of MAPKs.";
RL   Oncogene 26:3100-3112(2007).
RN   [12]
RP   REVIEW ON FUNCTION.
RX   PubMed=20801953; DOI=10.1093/jb/mvq098;
RA   Asaoka Y., Nishina H.;
RT   "Diverse physiological functions of MKK4 and MKK7 during early
RT   embryogenesis.";
RL   J. Biochem. 148:393-401(2010).
RN   [13]
RP   REVIEW ON REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=21333379; DOI=10.1016/j.ejcb.2010.11.008;
RA   Haeusgen W., Herdegen T., Waetzig V.;
RT   "The bottleneck of JNK signaling: molecular and functional
RT   characteristics of MKK4 and MKK7.";
RL   Eur. J. Cell Biol. 90:536-544(2011).
RN   [14]
RP   INTERACTION WITH SPAG9.
RX   PubMed=12391307; DOI=10.1073/pnas.232310199;
RA   Lee C.M., Onesime D., Reddy C.D., Dhanasekaran N., Reddy E.P.;
RT   "JLP: a scaffolding protein that tethers JNK/p38MAPK signaling modules
RT   and transcription factors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14189-14194(2002).
CC   -!- FUNCTION: Dual specificity protein kinase which acts as an
CC       essential component of the MAP kinase signal transduction pathway.
CC       Essential component of the stress-activated protein kinase/c-Jun
CC       N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7,
CC       is the one of the only known kinase to directly activate the
CC       stress-activated protein kinase/c-Jun N-terminal kinases
CC       MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and
CC       MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they
CC       differ in their preference for the phosphorylation site in the
CC       Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of
CC       the Tyr residue and MAP2K7/MKK7 for the Thr residue. The
CC       phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the
CC       prerequisite for JNK activation at least in response to
CC       proinflammatory cytokines, while other stimuli activate both
CC       MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate
CC       JNKs. MAP2K4 is required for maintaining peripheral lymphoid
CC       homeostasis. The MKK/JNK signaling pathway is also involved in
CC       mitochondrial death signaling pathway, including the release
CC       cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7
CC       exclusively activates JNKs, MAP2K4/MKK4 additionally activates the
CC       p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated in response to a variety of cellular
CC       stresses, including UV and gamma-irradiation, heat shock,
CC       hyperosmolarity, T-cell receptor stimulation, peroxide and
CC       inflammatory cytokines. Also activated by developmental cues.
CC       MAP2K4/MKK4 is activated by the majority of MKKKs, such as
CC       MAP3K5/ASK1, MAP3K1/MEKK1, MAP3K7/TAK1, MAP3K10/MLK2,
CC       MAP3K11/MLK3, MAP3K12/DLK and MAP3K13/LZK.
CC   -!- SUBUNIT: Interacts with SPAG9. Interacts (via its D domain) with
CC       its substrates MAPK8/JNK1, MAPK9/JNK2, MAPK10/JNK3, MAPK11 and
CC       MAPK14 (By similarity). Interacts (via its DVD domain) with MAP3Ks
CC       activators like MAP3K1/MEKK1 and MAP3K11/MLK3. Interacts with
CC       ARRB1, ARRB2 and MAPK8IP3/JIP3 (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- TISSUE SPECIFICITY: Strong expression is detected in most of the
CC       central nervous system and in liver and thymus during early stages
CC       of development. While expression in nervous system increases over
CC       time, expression in fetal liver and thymus gradually decreases as
CC       embryogenesis proceeds. High level of expression in the central
CC       nervous system persists throughout postnatal development and
CC       remained at a stable level in adult brain.
CC   -!- DOMAIN: The DVD domain (residues 362-385) contains a conserved
CC       docking site and is found in the mammalian MAP kinase kinases
CC       (MAP2Ks). The DVD sites bind to their specific upstream MAP kinase
CC       kinase kinases (MAP3Ks) and are essential for activation (By
CC       similarity).
CC   -!- DOMAIN: The D domain (residues 35-50) contains a conserved docking
CC       site and is required for the binding to MAPk substrates.
CC   -!- PTM: Activated by phosphorylation on Ser-255 and Thr-259 by MAP
CC       kinase kinase kinases (MAP3Ks) (By similarity).
CC   -!- DISRUPTION PHENOTYPE: Causes irregular alignment of Purkinje cells
CC       in the cerebellum and delayed radial migration in the cortex
CC       during brain development. The cardiac-specific deletion prevents
CC       pathological cardiac hypertrophy.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U18310; AAB81554.1; -; mRNA.
DR   PIR; S52423; S52423.
DR   RefSeq; NP_033183.1; NM_009157.4.
DR   UniGene; Mm.412922; -.
DR   ProteinModelPortal; P47809; -.
DR   SMR; P47809; 93-386.
DR   BioGrid; 204952; 7.
DR   DIP; DIP-869N; -.
DR   IntAct; P47809; 2.
DR   MINT; MINT-4102306; -.
DR   STRING; 10090.ENSMUSP00000041282; -.
DR   BindingDB; P47809; -.
DR   ChEMBL; CHEMBL2201; -.
DR   PhosphoSite; P47809; -.
DR   PaxDb; P47809; -.
DR   PRIDE; P47809; -.
DR   DNASU; 26398; -.
DR   Ensembl; ENSMUST00000046963; ENSMUSP00000041282; ENSMUSG00000033352.
DR   GeneID; 26398; -.
DR   KEGG; mmu:26398; -.
DR   UCSC; uc007jlb.1; mouse.
DR   CTD; 6416; -.
DR   MGI; MGI:1346869; Map2k4.
DR   eggNOG; COG0515; -.
DR   HOGENOM; HOG000234206; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; P47809; -.
DR   KO; K04430; -.
DR   OMA; VMKSNDC; -.
DR   OrthoDB; EOG7J9VPW; -.
DR   TreeFam; TF350701; -.
DR   BRENDA; 2.7.12.2; 3474.
DR   Reactome; REACT_98458; Immune System.
DR   NextBio; 304351; -.
DR   PRO; PR:P47809; -.
DR   ArrayExpress; P47809; -.
DR   Bgee; P47809; -.
DR   CleanEx; MM_MAP2K4; -.
DR   Genevestigator; P47809; -.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0032839; C:dendrite cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008545; F:JUN kinase kinase activity; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007257; P:activation of JUN kinase activity; ISO:MGI.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0072709; P:cellular response to sorbitol; IEA:Ensembl.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:GOC.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Apoptosis; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Stress response;
KW   Transferase; Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed (By similarity).
FT   CHAIN         2    397       Dual specificity mitogen-activated
FT                                protein kinase kinase 4.
FT                                /FTId=PRO_0000086382.
FT   DOMAIN      100    366       Protein kinase.
FT   NP_BIND     106    114       ATP (By similarity).
FT   REGION       35     50       D domain (By similarity).
FT   REGION      362    385       DVD domain (By similarity).
FT   COMPBIAS      5     17       Gly/Ser-rich.
FT   ACT_SITE    227    227       Proton acceptor (By similarity).
FT   BINDING     129    129       ATP.
FT   MOD_RES       2      2       N-acetylalanine (By similarity).
FT   MOD_RES      88     88       Phosphoserine (By similarity).
FT   MOD_RES     255    255       Phosphoserine; by MAP3K (By similarity).
FT   MOD_RES     259    259       Phosphothreonine; by MAP3K (By
FT                                similarity).
FT   MUTAGEN     129    129       K->R: Loss of ATP-binding.
SQ   SEQUENCE   397 AA;  44114 MW;  B99C6688184E5B3D CRC64;
     MAAPSPSGGG GSGGGGGTPG PIGPPASGHP AVSSMQGKRK ALKLNFANPP VKSTARFTLN
     PNTTGVQNPH IERLRTHSIE SSGKLKISPE QHWDFTAEDL KDLGEIGRGA YGSVNKMVHK
     PSGQIMAVKR IRSTVDEKEQ KQLLMDLDVV MRSSDCPYIV QFYGALFREG DCWICMELMS
     TSFDKFYKYV YSVLDDVIPE EILGKITLAT VKALNHLKEN LKIIHRDIKP SNILLDRSGN
     IKLCDFGISG QLVDSIAKTR DAGCRPYMAP ERIDPSASRQ GYDVRSDVWS LGITLYELAT
     GRFPYPKWNS VFDQLTQVVK GDPPQLSNSE EREFSPSFIN FVNLCLTKDE SKRPKYKELL
     KHPFILMYEE RTVEVACYVC KILDQMPATP SSPMYVD
//
ID   Q967X2_CIOIN            Unreviewed;       215 AA.
AC   Q967X2;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   19-FEB-2014, entry version 62.
DE   SubName: Full=Casein kinase II b;
DE   SubName: Full=Protein kinase Ck2-beta;
DE   SubName: Full=Uncharacterized protein;
GN   Name=CK2B; Synonyms=Ci-casein kinase II b, ck2b;
OS   Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis).
OC   Eukaryota; Metazoa; Chordata; Tunicata; Ascidiacea; Enterogona;
OC   Phlebobranchia; Cionidae; Ciona.
OX   NCBI_TaxID=7719;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12481130; DOI=10.1126/science.1080049;
RA   Dehal P., Satou Y., Campbell R.K., Chapman J., Degnan B.,
RA   De Tomaso A., Davidson B., Di Gregorio A., Gelpke M., Goodstein D.M.,
RA   Harafuji N., Hastings K.E., Ho I., Hotta K., Huang W., Kawashima T.,
RA   Lemaire P., Martinez D., Meinertzhagen I.A., Necula S., Nonaka M.,
RA   Putnam N., Rash S., Saiga H., Satake M., Terry A., Yamada L.,
RA   Wang H.G., Awazu S., Azumi K., Boore J., Branno M., Chin-Bow S.,
RA   DeSantis R., Doyle S., Francino P., Keys D.N., Haga S., Hayashi H.,
RA   Hino K., Imai K.S., Inaba K., Kano S., Kobayashi K., Kobayashi M.,
RA   Lee B.I., Makabe K.W., Manohar C., Matassi G., Medina M.,
RA   Mochizuki Y., Mount S., Morishita T., Miura S., Nakayama A.,
RA   Nishizaka S., Nomoto H., Ohta F., Oishi K., Rigoutsos I., Sano M.,
RA   Sasaki A., Sasakura Y., Shoguchi E., Shin-i T., Spagnuolo A.,
RA   Stainier D., Suzuki M.M., Tassy O., Takatori N., Tokuoka M., Yagi K.,
RA   Yoshizaki F., Wada S., Zhang C., Hyatt P.D., Larimer F., Detter C.,
RA   Doggett N., Glavina T., Hawkins T., Richardson P., Lucas S.,
RA   Kohara Y., Levine M., Satoh N., Rokhsar D.S.;
RT   "The draft genome of Ciona intestinalis: insights into chordate and
RT   vertebrate origins.";
RL   Science 298:2157-2167(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12736827; DOI=10.1007/s00427-003-0330-z;
RA   Satou Y., Satoh N.;
RT   "Genomewide surveys of developmentally relevant genes in Ciona
RT   intestinalis.";
RL   Dev. Genes Evol. 213:211-212(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=15269171; DOI=10.1242/dev.01270;
RA   Imai K.S., Hino K., Yagi K., Satoh N., Satou Y.;
RT   "Gene expression profiles of transcription factors and signaling
RT   molecules in the ascidian embryo: towards a comprehensive
RT   understanding of gene networks.";
RL   Development 131:4047-4058(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=15159401; DOI=10.1074/jbc.M401085200;
RA   Russo G.L., Tosto M., Mupo A., Castellano I., Cuomo A., Tosti E.;
RT   "Biochemical and functional characterization of protein kinase CK2 in
RT   ascidian Ciona intestinalis oocytes at fertilization. Cloning and
RT   sequence analysis of cDNA for alpha and beta subunits.";
RL   J. Biol. Chem. 279:33012-33023(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE.
RA   Satou Y.;
RT   "Expressed genes in Ciona intestinalis.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EAAA01000113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF360544; AAK50003.1; -; mRNA.
DR   EMBL; AB210337; BAE06342.1; -; mRNA.
DR   RefSeq; NP_001027591.1; NM_001032419.1.
DR   UniGene; Cin.23263; -.
DR   ProteinModelPortal; Q967X2; -.
DR   SMR; Q967X2; 2-204.
DR   STRING; 7719.ENSCINP00000025110; -.
DR   Ensembl; ENSCINT00000008085; ENSCINP00000008085; ENSCING00000003902.
DR   GeneID; 445589; -.
DR   KEGG; cin:445589; -.
DR   CTD; 30428; -.
DR   eggNOG; COG5041; -.
DR   GeneTree; ENSGT00390000003781; -.
DR   HOGENOM; HOG000039270; -.
DR   HOVERGEN; HBG051131; -.
DR   KO; K03115; -.
DR   OMA; TNQFVPR; -.
DR   OrthoDB; EOG7GTT4V; -.
DR   TreeFam; TF314462; -.
DR   GO; GO:0005956; C:protein kinase CK2 complex; IEA:InterPro.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:InterPro.
DR   GO; GO:0045859; P:regulation of protein kinase activity; IEA:GOC.
DR   Gene3D; 1.10.1820.10; -; 1.
DR   Gene3D; 2.20.25.20; -; 1.
DR   InterPro; IPR016149; Casein_kin_II_reg-sub_a-hlx.
DR   InterPro; IPR016150; Casein_kin_II_reg-sub_b-sht.
DR   InterPro; IPR000704; Casein_kinase_II_reg-sub.
DR   PANTHER; PTHR11740; PTHR11740; 1.
DR   Pfam; PF01214; CK_II_beta; 1.
DR   PRINTS; PR00472; CASNKINASEII.
DR   SMART; SM01085; CK_II_beta; 1.
DR   SUPFAM; SSF57798; SSF57798; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Kinase; Reference proteome; Transferase.
SQ   SEQUENCE   215 AA;  24938 MW;  62A43DCB6C6CEF3F CRC64;
     MSSSEEVSWI SWFCGLRGNE FFCEVDEDYI QDKFNLTGLG EQVPHYRQAL DMILDLEPDD
     DLEDNTNQSD LIEQAAEMLY GLIHARYTLT NRGIAQMLEK YQQGDFGHCS RVYCENQPML
     PIGLSDVPGE AMVKLYCPKC QDVYTPKSSR HHHTDGAYFG TGFPHMLFMV HPEYRPKRPT
     NQFVSRLFGF KIHPMAYQLQ YQASQKLKNP SKLRH
//
ID   A7RQU9_NEMVE            Unreviewed;       376 AA.
AC   A7RQU9;
DT   02-OCT-2007, integrated into UniProtKB/TrEMBL.
DT   02-OCT-2007, sequence version 1.
DT   19-MAR-2014, entry version 43.
DE   SubName: Full=Cytoplasmic creatine kinase protein;
DE   SubName: Full=Predicted protein;
GN   Name=cytoplasmic creatine kinase; ORFNames=v1g234345;
OS   Nematostella vectensis (Starlet sea anemone).
OC   Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
OC   Edwardsiidae; Nematostella.
OX   NCBI_TaxID=45351;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=CH2 X CH6;
RX   PubMed=17615350; DOI=10.1126/science.1139158;
RA   Putnam N.H., Srivastava M., Hellsten U., Dirks B., Chapman J.,
RA   Salamov A., Terry A., Shapiro H., Lindquist E., Kapitonov V.V.,
RA   Jurka J., Genikhovich G., Grigoriev I.V., Lucas S.M., Steele R.E.,
RA   Finnerty J.R., Technau U., Martindale M.Q., Rokhsar D.S.;
RT   "Sea anemone genome reveals ancestral eumetazoan gene repertoire and
RT   genomic organization.";
RL   Science 317:86-94(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22305986; DOI=10.1016/j.gene.2012.01.036;
RA   Uda K., Ellington W.R., Suzuki T.;
RT   "A diverse array of creatine kinase and arginine kinase isoform genes
RT   is present in the starlet sea anemone Nematostella vectensis, a
RT   cnidarian model system for studying developmental evolution.";
RL   Gene 497:214-227(2012).
CC   -!- SIMILARITY: Belongs to the ATP:guanido phosphotransferase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB665525; BAL73226.1; -; mRNA.
DR   EMBL; DS469529; EDO46231.1; -; Genomic_DNA.
DR   RefSeq; XP_001638294.1; XM_001638244.1.
DR   UniGene; Nve.5206; -.
DR   ProteinModelPortal; A7RQU9; -.
DR   SMR; A7RQU9; 10-375.
DR   STRING; 45351.JGI234345; -.
DR   EnsemblMetazoa; NEMVEDRAFT_v1g234345-RA; NEMVEDRAFT_v1g234345-PA; NEMVEDRAFT_v1g234345.
DR   GeneID; 5518278; -.
DR   KEGG; nve:NEMVE_v1g234345; -.
DR   eggNOG; COG3869; -.
DR   HOGENOM; HOG000232165; -.
DR   KO; K00933; -.
DR   OMA; RGHEFMW; -.
DR   OrthoDB; EOG7XM2XW; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.135.10; -; 1.
DR   Gene3D; 3.30.590.10; -; 1.
DR   InterPro; IPR022415; ATP-guanido_PTrfase_AS.
DR   InterPro; IPR022414; ATP-guanido_PTrfase_cat.
DR   InterPro; IPR022413; ATP-guanido_PTrfase_N.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   Pfam; PF00217; ATP-gua_Ptrans; 1.
DR   Pfam; PF02807; ATP-gua_PtransN; 1.
DR   SUPFAM; SSF48034; SSF48034; 1.
DR   PROSITE; PS00112; PHOSPHAGEN_KINASE; 1.
DR   PROSITE; PS51510; PHOSPHAGEN_KINASE_C; 1.
DR   PROSITE; PS51509; PHOSPHAGEN_KINASE_N; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Reference proteome; Transferase.
SQ   SEQUENCE   376 AA;  42117 MW;  D5933E6281037882 CRC64;
     MTSVKSAYKQ FSADDDFPDL SQHNNYMAKV LTKEIYRSLR DKSTKNGFTL DDIIQTGVDN
     PGHPFIMTVG CVAGDEESYD VFAELLDPVI ELRHGGYKKT DKHKTDLNPD NLKGGALDPK
     YVLSSRVRTG RSIRGFCLPP HCSRAERRSV EKISVDALAK LDGEFKGKYY PLNKMTDEEQ
     EQLINDHFLF DKPVSPLLTC AGMARDWPDA RGIWHNENKN FLVWVNEEDH TRVISMEKGG
     DMRAVFTRFC NGLNKVESLI KEAGYEFMWN EHLGYVLTCP SNLGTGLRAG VHLKIPLLSQ
     DEKRLDAILA KLKLQKRGTG GVDTASVGGV YDISNADRIG FSEVELVQGM VDGVGLLIEM
     EKRLEEGKAI DDLIPK
//
ID   MP2K7_HUMAN             Reviewed;         419 AA.
AC   O14733; B2R9S5; D6W659; O14648; O14816; O60452; O60453; Q1PG43;
AC   Q8IY10;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   19-MAR-2014, entry version 139.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 7;
DE            Short=MAP kinase kinase 7;
DE            Short=MAPKK 7;
DE            EC=2.7.12.2;
DE   AltName: Full=JNK-activating kinase 2;
DE   AltName: Full=MAPK/ERK kinase 7;
DE            Short=MEK 7;
DE   AltName: Full=Stress-activated protein kinase kinase 4;
DE            Short=SAPK kinase 4;
DE            Short=SAPKK-4;
DE            Short=SAPKK4;
DE   AltName: Full=c-Jun N-terminal kinase kinase 2;
DE            Short=JNK kinase 2;
DE            Short=JNKK 2;
GN   Name=MAP2K7; Synonyms=JNKK2, MEK7, MKK7, PRKMK7, SKK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart, and Skeletal muscle;
RX   PubMed=9372971;
RA   Wu Z., Wu J., Jacinto E., Karin M.;
RT   "Molecular cloning and characterization of human JNKK2, a novel jun
RT   NH2-terminal kinase-specific kinase.";
RL   Mol. Cell. Biol. 17:7407-7416(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND ENZYME
RP   REGULATION.
RX   PubMed=9312068; DOI=10.1074/jbc.272.40.24751;
RA   Lu X., Nemoto S., Lin A.;
RT   "Identification of c-Jun NH2-terminal protein kinase (JNK)-activating
RT   kinase 2 as an activator of JNK but not p38.";
RL   J. Biol. Chem. 272:24751-24754(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND VARIANT PHE-259.
RC   TISSUE=Fetal kidney;
RX   PubMed=9535930; DOI=10.1074/jbc.273.15.9344;
RA   Foltz I.N., Gerl R.E., Wieler J.S., Luckach M., Salmon R.A.,
RA   Schrader J.W.;
RT   "Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly
RT   conserved c-Jun N-terminal kinase/stress-activated protein kinase
RT   (JNK/SAPK) activated by environmental stresses and physiological
RT   stimuli.";
RL   J. Biol. Chem. 273:9344-9351(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16442502; DOI=10.1016/j.bbrc.2005.12.223;
RA   Michael L., Swantek J., Robinson M.J.;
RT   "Cloning and expression of human mitogen-activated protein kinase
RT   kinase 7gamma1.";
RL   Biochem. Biophys. Res. Commun. 341:679-683(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION IN
RP   PHOSPHORYLATION OF MAPK8/JNK1 AND MAPK9/JNK2.
RA   Yang J., New L., Yong J., Han J., Su B.;
RT   "Molecular cloning of human JNKK2 reveals a novel kinase module for c-
RT   Jun N-terminal kinase activation.";
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-260 (ISOFORMS 1/4).
RX   PubMed=9207092; DOI=10.1073/pnas.94.14.7337;
RA   Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J.;
RT   "Mitogen-activated protein kinase kinase 7 is an activator of the c-
RT   Jun NH2-terminal kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7337-7342(1997).
RN   [10]
RP   INTERACTION WITH MAPK8IP1/JIP1 AND MAPK8IP2/JIP2.
RX   PubMed=10490659;
RA   Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., Davis R.J.;
RT   "The JIP group of mitogen-activated protein kinase scaffold
RT   proteins.";
RL   Mol. Cell. Biol. 19:7245-7254(1999).
RN   [11]
RP   CLEAVAGE BY ANTHRAX LETHAL FACTOR.
RX   PubMed=11104681; DOI=10.1042/0264-6021:3520739;
RA   Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C.;
RT   "Susceptibility of mitogen-activated protein kinase kinase family
RT   members to proteolysis by anthrax lethal factor.";
RL   Biochem. J. 352:739-745(2000).
RN   [12]
RP   INTERACTION WITH MAPK8IP3/JIP3.
RX   PubMed=12189133; DOI=10.1074/jbc.M202004200;
RA   Matsuura H., Nishitoh H., Takeda K., Matsuzawa A., Amagasa T., Ito M.,
RA   Yoshioka K., Ichijo H.;
RT   "Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-
RT   JNK signaling pathway. A new mode of regulation of the MAP kinase
RT   cascade.";
RL   J. Biol. Chem. 277:40703-40709(2002).
RN   [13]
RP   DOMAIN.
RX   PubMed=15866172; DOI=10.1016/j.molcel.2005.04.001;
RA   Takekawa M., Tatebayashi K., Saito H.;
RT   "Conserved docking site is essential for activation of mammalian MAP
RT   kinase kinases by specific MAP kinase kinase kinases.";
RL   Mol. Cell 18:295-306(2005).
RN   [14]
RP   INTERACTION WITH VRK2.
RX   PubMed=18286207; DOI=10.1371/journal.pone.0001660;
RA   Blanco S., Sanz-Garcia M., Santos C.R., Lazo P.A.;
RT   "Modulation of interleukin-1 transcriptional response by the
RT   interaction between VRK2 and the JIP1 scaffold protein.";
RL   PLoS ONE 3:E1660-E1660(2008).
RN   [15]
RP   REVIEW ON ENZYME REGULATION.
RX   PubMed=17496909; DOI=10.1038/sj.onc.1210392;
RA   Raman M., Chen W., Cobb M.H.;
RT   "Differential regulation and properties of MAPKs.";
RL   Oncogene 26:3100-3112(2007).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS], AND CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   REVIEW ON FUNCTION.
RX   PubMed=20801953; DOI=10.1093/jb/mvq098;
RA   Asaoka Y., Nishina H.;
RT   "Diverse physiological functions of MKK4 and MKK7 during early
RT   embryogenesis.";
RL   J. Biochem. 148:393-401(2010).
RN   [18]
RP   INTERACTION WITH RASSF7.
RX   PubMed=21278800; DOI=10.1038/cdd.2010.137;
RA   Takahashi S., Ebihara A., Kajiho H., Kontani K., Nishina H.,
RA   Katada T.;
RT   "RASSF7 negatively regulates pro-apoptotic JNK signaling by inhibiting
RT   the activity of phosphorylated-MKK7.";
RL   Cell Death Differ. 18:645-655(2011).
RN   [19]
RP   REVIEW ON REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=21333379; DOI=10.1016/j.ejcb.2010.11.008;
RA   Haeusgen W., Herdegen T., Waetzig V.;
RT   "The bottleneck of JNK signaling: molecular and functional
RT   characteristics of MKK4 and MKK7.";
RL   Eur. J. Cell Biol. 90:536-544(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 101-405.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of human mitogen-activated protein kinase kinase 7
RT   activated mutant (s287d, t291d).";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-118; CYS-138; CYS-162; HIS-162 AND
RP   THR-195.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity protein kinase which acts as an
CC       essential component of the MAP kinase signal transduction pathway.
CC       Essential component of the stress-activated protein kinase/c-Jun
CC       N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K4/MKK4,
CC       is the one of the only known kinase to directly activate the
CC       stress-activated protein kinase/c-Jun N-terminal kinases
CC       MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and
CC       MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they
CC       differ in their preference for the phosphorylation site in the
CC       Thr-Pro-Tyr motif. MAP2K4/MKK4 shows preference for
CC       phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr
CC       residue. The monophosphorylation of JNKs on the Thr residue is
CC       sufficient to increase JNK activity indicating that MAP2K7/MKK7 is
CC       important to trigger JNK activity, while the additional
CC       phosphorylation of the Tyr residue by MAP2K4/MKK4 ensures optimal
CC       JNK activation. Has a specific role in JNK signal transduction
CC       pathway activated by proinflammatory cytokines. The MKK/JNK
CC       signaling pathway is also involved in mitochondrial death
CC       signaling pathway, including the release cytochrome c, leading to
CC       apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation by specific MAP
CC       kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3,
CC       MAP3K11/MLK3 and MAP3K12/DLK.
CC   -!- SUBUNIT: Interacts with isoform 1 of VRK2. Interacts (via its D
CC       domain) with its substrates MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3
CC       (By similarity). Interacts (via its DVD domain) with MAP3Ks
CC       activators like MAP3K5/ASK1 and MAP3K1/MEKK1 (By similarity).
CC       Interacts with MAPK8IP1/JIP1, MAPK8IP2/JIP2 and MAPK8IP3/JIP3
CC       scaffold proteins. Interacts with RASSF7, the interaction promotes
CC       phosphorylation.
CC   -!- INTERACTION:
CC       O15519-1:CFLAR; NbExp=2; IntAct=EBI-492605, EBI-4567563;
CC       Q5S007:LRRK2; NbExp=3; IntAct=EBI-492605, EBI-5323863;
CC       O43318:MAP3K7; NbExp=2; IntAct=EBI-492605, EBI-358684;
CC       P45983:MAPK8; NbExp=3; IntAct=EBI-492627, EBI-286483;
CC       Q9UQF2:MAPK8IP1; NbExp=5; IntAct=EBI-492605, EBI-78404;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=O14733-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=O14733-2; Sequence=VSP_004883;
CC         Note=May be due to intron retention;
CC       Name=3; Synonyms=gamma1;
CC         IsoId=O14733-3; Sequence=VSP_022309;
CC       Name=4;
CC         IsoId=O14733-4; Sequence=VSP_022310;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; with highest level of expression
CC       in skeletal muscle. Isoform 3 is found at low levels in placenta,
CC       fetal liver, and skeletal muscle.
CC   -!- DOMAIN: The DVD domain (residues 377-400) contains a conserved
CC       docking site and is found in the mammalian MAP kinase kinases
CC       (MAP2Ks). The DVD sites bind to their specific upstream MAP kinase
CC       kinase kinases (MAP3Ks) and are essential for activation.
CC   -!- DOMAIN: The D domain (residues 37-57) contains a conserved docking
CC       site and is required for the binding to MAPK substrates.
CC   -!- PTM: Activated by phosphorylation on Ser-271 and Thr-275 by MAP
CC       kinase kinase kinases (MAP3Ks) (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB97813.1; Type=Erroneous termination; Positions=420; Note=Translated as stop;
CC       Sequence=AAB97813.1; Type=Frameshift; Positions=402, 410;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF014401; AAB88048.1; -; mRNA.
DR   EMBL; AF006689; AAB97813.1; ALT_SEQ; mRNA.
DR   EMBL; AF013588; AAC16272.1; -; mRNA.
DR   EMBL; AF013589; AAC16273.1; -; mRNA.
DR   EMBL; DQ445915; ABE03013.1; -; mRNA.
DR   EMBL; AF022805; AAC26142.1; -; mRNA.
DR   EMBL; AK313899; BAG36622.1; -; mRNA.
DR   EMBL; CH471139; EAW68964.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68968.1; -; Genomic_DNA.
DR   EMBL; BC038295; AAH38295.1; -; mRNA.
DR   EMBL; AF003199; AAB63374.1; -; mRNA.
DR   RefSeq; NP_660186.1; NM_145185.2.
DR   RefSeq; XP_005272546.1; XM_005272489.1.
DR   RefSeq; XP_005272547.1; XM_005272490.1.
DR   UniGene; Hs.531754; -.
DR   PDB; 2DYL; X-ray; 2.45 A; A=101-405.
DR   PDBsum; 2DYL; -.
DR   ProteinModelPortal; O14733; -.
DR   SMR; O14733; 53-402.
DR   BioGrid; 111595; 34.
DR   IntAct; O14733; 18.
DR   MINT; MINT-1378223; -.
DR   STRING; 9606.ENSP00000381066; -.
DR   BindingDB; O14733; -.
DR   ChEMBL; CHEMBL3530; -.
DR   DrugBank; DB00773; Etoposide.
DR   GuidetoPHARMACOLOGY; 2068; -.
DR   PhosphoSite; O14733; -.
DR   PaxDb; O14733; -.
DR   PRIDE; O14733; -.
DR   DNASU; 5609; -.
DR   Ensembl; ENST00000397979; ENSP00000381066; ENSG00000076984. [O14733-1]
DR   Ensembl; ENST00000397981; ENSP00000381068; ENSG00000076984. [O14733-4]
DR   Ensembl; ENST00000397983; ENSP00000381070; ENSG00000076984. [O14733-3]
DR   GeneID; 5609; -.
DR   KEGG; hsa:5609; -.
DR   UCSC; uc002mit.3; human. [O14733-1]
DR   UCSC; uc002miv.2; human. [O14733-4]
DR   CTD; 5609; -.
DR   GeneCards; GC19P007968; -.
DR   HGNC; HGNC:6847; MAP2K7.
DR   HPA; CAB004262; -.
DR   HPA; HPA001633; -.
DR   MIM; 603014; gene.
DR   neXtProt; NX_O14733; -.
DR   PharmGKB; PA284; -.
DR   eggNOG; COG0515; -.
DR   HOVERGEN; HBG108518; -.
DR   KO; K04431; -.
DR   OrthoDB; EOG7J9VPW; -.
DR   TreeFam; TF350701; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   Reactome; REACT_120956; Cellular responses to stress.
DR   Reactome; REACT_6782; TRAF6 Mediated Induction of proinflammatory cytokines.
DR   Reactome; REACT_6900; Immune System.
DR   SignaLink; O14733; -.
DR   EvolutionaryTrace; O14733; -.
DR   GeneWiki; MAP2K7; -.
DR   GenomeRNAi; 5609; -.
DR   NextBio; 21802; -.
DR   PMAP-CutDB; O14733; -.
DR   PRO; PR:O14733; -.
DR   ArrayExpress; O14733; -.
DR   Bgee; O14733; -.
DR   CleanEx; HS_MAP2K7; -.
DR   Genevestigator; O14733; -.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008545; F:JUN kinase kinase activity; IEA:Ensembl.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007257; P:activation of JUN kinase activity; ISS:BHF-UCL.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0072709; P:cellular response to sorbitol; IEA:Ensembl.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:GOC.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0034166; P:toll-like receptor 10 signaling pathway; TAS:Reactome.
DR   GO; GO:0034134; P:toll-like receptor 2 signaling pathway; TAS:Reactome.
DR   GO; GO:0034138; P:toll-like receptor 3 signaling pathway; TAS:Reactome.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; TAS:Reactome.
DR   GO; GO:0034146; P:toll-like receptor 5 signaling pathway; TAS:Reactome.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; TAS:Reactome.
DR   GO; GO:0038123; P:toll-like receptor TLR1:TLR2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038124; P:toll-like receptor TLR6:TLR2 signaling pathway; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   ATP-binding; Coiled coil; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Stress response; Transferase; Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    419       Dual specificity mitogen-activated
FT                                protein kinase kinase 7.
FT                                /FTId=PRO_0000086388.
FT   DOMAIN      120    380       Protein kinase.
FT   NP_BIND     126    134       ATP (By similarity).
FT   REGION       37     57       D domain (By similarity).
FT   REGION      377    400       DVD domain.
FT   COILED        2     30       Potential.
FT   ACT_SITE    243    243       Proton acceptor (By similarity).
FT   BINDING     149    149       ATP (By similarity).
FT   SITE         44     45       Cleavage; by anthrax lethal factor.
FT   SITE         76     77       Cleavage; by anthrax lethal factor.
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     271    271       Phosphoserine; by MAP3K (By similarity).
FT   MOD_RES     275    275       Phosphothreonine; by MAP3K (By
FT                                similarity).
FT   VAR_SEQ      42     42       T -> IIVITLSPAPAPSQRAA (in isoform 3).
FT                                /FTId=VSP_022309.
FT   VAR_SEQ     111    111       Q -> QVPPSLWRGEGGGPARLDPSWERQWGAGGGGRAPGT
FT                                LQPSLSSQ (in isoform 2).
FT                                /FTId=VSP_004883.
FT   VAR_SEQ     312    312       L -> LPCPSPSQ (in isoform 4).
FT                                /FTId=VSP_022310.
FT   VARIANT     118    118       N -> S (in dbSNP:rs56316660).
FT                                /FTId=VAR_040825.
FT   VARIANT     138    138       R -> C (in dbSNP:rs56106612).
FT                                /FTId=VAR_040826.
FT   VARIANT     162    162       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040827.
FT   VARIANT     162    162       R -> H (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040828.
FT   VARIANT     195    195       A -> T (in dbSNP:rs55800262).
FT                                /FTId=VAR_040829.
FT   VARIANT     259    259       L -> F (in dbSNP:rs1053566).
FT                                /FTId=VAR_029890.
FT   CONFLICT     94     94       Q -> H (in Ref. 2; AAB97813).
FT   CONFLICT    106    106       L -> P (in Ref. 4; ABE03013).
FT   CONFLICT    133    133       Q -> P (in Ref. 2; AAB97813).
FT   CONFLICT    142    142       T -> N (in Ref. 1; AAB88048).
FT   CONFLICT    407    407       S -> N (in Ref. 2; AAB97813).
FT   CONFLICT    415    415       L -> LG (in Ref. 2; AAB97813).
FT   STRAND      105    114
FT   HELIX       117    119
FT   STRAND      120    125
FT   STRAND      134    139
FT   TURN        140    142
FT   STRAND      145    152
FT   HELIX       157    172
FT   TURN        173    175
FT   STRAND      182    187
FT   STRAND      189    196
FT   STRAND      200    202
FT   HELIX       203    210
FT   HELIX       216    237
FT   HELIX       246    248
FT   STRAND      249    251
FT   STRAND      257    259
FT   HELIX       286    289
FT   HELIX       302    317
FT   TURN        321    324
FT   HELIX       328    337
FT   STRAND      345    347
FT   HELIX       351    360
FT   TURN        365    367
FT   HELIX       371    374
FT   HELIX       378    385
FT   HELIX       390    399
SQ   SEQUENCE   419 AA;  47485 MW;  F1B22E050F54299A CRC64;
     MAASSLEQKL SRLEAKLKQE NREARRRIDL NLDISPQRPR PTLQLPLAND GGSRSPSSES
     SPQHPTPPAR PRHMLGLPST LFTPRSMESI EIDQKLQEIM KQTGYLTIGG QRYQAEINDL
     ENLGEMGSGT CGQVWKMRFR KTGHVIAVKQ MRRSGNKEEN KRILMDLDVV LKSHDCPYIV
     QCFGTFITNT DVFIAMELMG TCAEKLKKRM QGPIPERILG KMTVAIVKAL YYLKEKHGVI
     HRDVKPSNIL LDERGQIKLC DFGISGRLVD SKAKTRSAGC AAYMAPERID PPDPTKPDYD
     IRADVWSLGI SLVELATGQF PYKNCKTDFE VLTKVLQEEP PLLPGHMGFS GDFQSFVKDC
     LTKDHRKRPK YNKLLEHSFI KRYETLEVDV ASWFKDVMAK TESPRTSGVL SQPHLPFFR
//
ID   Q967X2_CIOIN            Unreviewed;       215 AA.
AC   Q967X2;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   19-FEB-2014, entry version 62.
DE   SubName: Full=Casein kinase II b;
DE   SubName: Full=Protein kinase Ck2-beta;
DE   SubName: Full=Uncharacterized protein;
GN   Name=CK2B; Synonyms=Ci-casein kinase II b, ck2b;
OS   Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis).
OC   Eukaryota; Metazoa; Chordata; Tunicata; Ascidiacea; Enterogona;
OC   Phlebobranchia; Cionidae; Ciona.
OX   NCBI_TaxID=7719;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12481130; DOI=10.1126/science.1080049;
RA   Dehal P., Satou Y., Campbell R.K., Chapman J., Degnan B.,
RA   De Tomaso A., Davidson B., Di Gregorio A., Gelpke M., Goodstein D.M.,
RA   Harafuji N., Hastings K.E., Ho I., Hotta K., Huang W., Kawashima T.,
RA   Lemaire P., Martinez D., Meinertzhagen I.A., Necula S., Nonaka M.,
RA   Putnam N., Rash S., Saiga H., Satake M., Terry A., Yamada L.,
RA   Wang H.G., Awazu S., Azumi K., Boore J., Branno M., Chin-Bow S.,
RA   DeSantis R., Doyle S., Francino P., Keys D.N., Haga S., Hayashi H.,
RA   Hino K., Imai K.S., Inaba K., Kano S., Kobayashi K., Kobayashi M.,
RA   Lee B.I., Makabe K.W., Manohar C., Matassi G., Medina M.,
RA   Mochizuki Y., Mount S., Morishita T., Miura S., Nakayama A.,
RA   Nishizaka S., Nomoto H., Ohta F., Oishi K., Rigoutsos I., Sano M.,
RA   Sasaki A., Sasakura Y., Shoguchi E., Shin-i T., Spagnuolo A.,
RA   Stainier D., Suzuki M.M., Tassy O., Takatori N., Tokuoka M., Yagi K.,
RA   Yoshizaki F., Wada S., Zhang C., Hyatt P.D., Larimer F., Detter C.,
RA   Doggett N., Glavina T., Hawkins T., Richardson P., Lucas S.,
RA   Kohara Y., Levine M., Satoh N., Rokhsar D.S.;
RT   "The draft genome of Ciona intestinalis: insights into chordate and
RT   vertebrate origins.";
RL   Science 298:2157-2167(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12736827; DOI=10.1007/s00427-003-0330-z;
RA   Satou Y., Satoh N.;
RT   "Genomewide surveys of developmentally relevant genes in Ciona
RT   intestinalis.";
RL   Dev. Genes Evol. 213:211-212(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=15269171; DOI=10.1242/dev.01270;
RA   Imai K.S., Hino K., Yagi K., Satoh N., Satou Y.;
RT   "Gene expression profiles of transcription factors and signaling
RT   molecules in the ascidian embryo: towards a comprehensive
RT   understanding of gene networks.";
RL   Development 131:4047-4058(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=15159401; DOI=10.1074/jbc.M401085200;
RA   Russo G.L., Tosto M., Mupo A., Castellano I., Cuomo A., Tosti E.;
RT   "Biochemical and functional characterization of protein kinase CK2 in
RT   ascidian Ciona intestinalis oocytes at fertilization. Cloning and
RT   sequence analysis of cDNA for alpha and beta subunits.";
RL   J. Biol. Chem. 279:33012-33023(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE.
RA   Satou Y.;
RT   "Expressed genes in Ciona intestinalis.";
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EAAA01000113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF360544; AAK50003.1; -; mRNA.
DR   EMBL; AB210337; BAE06342.1; -; mRNA.
DR   RefSeq; NP_001027591.1; NM_001032419.1.
DR   UniGene; Cin.23263; -.
DR   ProteinModelPortal; Q967X2; -.
DR   SMR; Q967X2; 2-204.
DR   STRING; 7719.ENSCINP00000025110; -.
DR   Ensembl; ENSCINT00000008085; ENSCINP00000008085; ENSCING00000003902.
DR   GeneID; 445589; -.
DR   KEGG; cin:445589; -.
DR   CTD; 30428; -.
DR   eggNOG; COG5041; -.
DR   GeneTree; ENSGT00390000003781; -.
DR   HOGENOM; HOG000039270; -.
DR   HOVERGEN; HBG051131; -.
DR   KO; K03115; -.
DR   OMA; TNQFVPR; -.
DR   OrthoDB; EOG7GTT4V; -.
DR   TreeFam; TF314462; -.
DR   GO; GO:0005956; C:protein kinase CK2 complex; IEA:InterPro.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:InterPro.
DR   GO; GO:0045859; P:regulation of protein kinase activity; IEA:GOC.
DR   Gene3D; 1.10.1820.10; -; 1.
DR   Gene3D; 2.20.25.20; -; 1.
DR   InterPro; IPR016149; Casein_kin_II_reg-sub_a-hlx.
DR   InterPro; IPR016150; Casein_kin_II_reg-sub_b-sht.
DR   InterPro; IPR000704; Casein_kinase_II_reg-sub.
DR   PANTHER; PTHR11740; PTHR11740; 1.
DR   Pfam; PF01214; CK_II_beta; 1.
DR   PRINTS; PR00472; CASNKINASEII.
DR   SMART; SM01085; CK_II_beta; 1.
DR   SUPFAM; SSF57798; SSF57798; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Kinase; Reference proteome; Transferase.
SQ   SEQUENCE   215 AA;  24938 MW;  62A43DCB6C6CEF3F CRC64;
     MSSSEEVSWI SWFCGLRGNE FFCEVDEDYI QDKFNLTGLG EQVPHYRQAL DMILDLEPDD
     DLEDNTNQSD LIEQAAEMLY GLIHARYTLT NRGIAQMLEK YQQGDFGHCS RVYCENQPML
     PIGLSDVPGE AMVKLYCPKC QDVYTPKSSR HHHTDGAYFG TGFPHMLFMV HPEYRPKRPT
     NQFVSRLFGF KIHPMAYQLQ YQASQKLKNP SKLRH
//
ID   A7RQU9_NEMVE            Unreviewed;       376 AA.
AC   A7RQU9;
DT   02-OCT-2007, integrated into UniProtKB/TrEMBL.
DT   02-OCT-2007, sequence version 1.
DT   19-MAR-2014, entry version 43.
DE   SubName: Full=Cytoplasmic creatine kinase protein;
DE   SubName: Full=Predicted protein;
GN   Name=cytoplasmic creatine kinase; ORFNames=v1g234345;
OS   Nematostella vectensis (Starlet sea anemone).
OC   Eukaryota; Metazoa; Cnidaria; Anthozoa; Hexacorallia; Actiniaria;
OC   Edwardsiidae; Nematostella.
OX   NCBI_TaxID=45351;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=CH2 X CH6;
RX   PubMed=17615350; DOI=10.1126/science.1139158;
RA   Putnam N.H., Srivastava M., Hellsten U., Dirks B., Chapman J.,
RA   Salamov A., Terry A., Shapiro H., Lindquist E., Kapitonov V.V.,
RA   Jurka J., Genikhovich G., Grigoriev I.V., Lucas S.M., Steele R.E.,
RA   Finnerty J.R., Technau U., Martindale M.Q., Rokhsar D.S.;
RT   "Sea anemone genome reveals ancestral eumetazoan gene repertoire and
RT   genomic organization.";
RL   Science 317:86-94(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22305986; DOI=10.1016/j.gene.2012.01.036;
RA   Uda K., Ellington W.R., Suzuki T.;
RT   "A diverse array of creatine kinase and arginine kinase isoform genes
RT   is present in the starlet sea anemone Nematostella vectensis, a
RT   cnidarian model system for studying developmental evolution.";
RL   Gene 497:214-227(2012).
CC   -!- SIMILARITY: Belongs to the ATP:guanido phosphotransferase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB665525; BAL73226.1; -; mRNA.
DR   EMBL; DS469529; EDO46231.1; -; Genomic_DNA.
DR   RefSeq; XP_001638294.1; XM_001638244.1.
DR   UniGene; Nve.5206; -.
DR   ProteinModelPortal; A7RQU9; -.
DR   SMR; A7RQU9; 10-375.
DR   STRING; 45351.JGI234345; -.
DR   EnsemblMetazoa; NEMVEDRAFT_v1g234345-RA; NEMVEDRAFT_v1g234345-PA; NEMVEDRAFT_v1g234345.
DR   GeneID; 5518278; -.
DR   KEGG; nve:NEMVE_v1g234345; -.
DR   eggNOG; COG3869; -.
DR   HOGENOM; HOG000232165; -.
DR   KO; K00933; -.
DR   OMA; RGHEFMW; -.
DR   OrthoDB; EOG7XM2XW; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.135.10; -; 1.
DR   Gene3D; 3.30.590.10; -; 1.
DR   InterPro; IPR022415; ATP-guanido_PTrfase_AS.
DR   InterPro; IPR022414; ATP-guanido_PTrfase_cat.
DR   InterPro; IPR022413; ATP-guanido_PTrfase_N.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   Pfam; PF00217; ATP-gua_Ptrans; 1.
DR   Pfam; PF02807; ATP-gua_PtransN; 1.
DR   SUPFAM; SSF48034; SSF48034; 1.
DR   PROSITE; PS00112; PHOSPHAGEN_KINASE; 1.
DR   PROSITE; PS51510; PHOSPHAGEN_KINASE_C; 1.
DR   PROSITE; PS51509; PHOSPHAGEN_KINASE_N; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Reference proteome; Transferase.
SQ   SEQUENCE   376 AA;  42117 MW;  D5933E6281037882 CRC64;
     MTSVKSAYKQ FSADDDFPDL SQHNNYMAKV LTKEIYRSLR DKSTKNGFTL DDIIQTGVDN
     PGHPFIMTVG CVAGDEESYD VFAELLDPVI ELRHGGYKKT DKHKTDLNPD NLKGGALDPK
     YVLSSRVRTG RSIRGFCLPP HCSRAERRSV EKISVDALAK LDGEFKGKYY PLNKMTDEEQ
     EQLINDHFLF DKPVSPLLTC AGMARDWPDA RGIWHNENKN FLVWVNEEDH TRVISMEKGG
     DMRAVFTRFC NGLNKVESLI KEAGYEFMWN EHLGYVLTCP SNLGTGLRAG VHLKIPLLSQ
     DEKRLDAILA KLKLQKRGTG GVDTASVGGV YDISNADRIG FSEVELVQGM VDGVGLLIEM
     EKRLEEGKAI DDLIPK
//
ID   Q9NA00_9CRUS            Unreviewed;       494 AA.
AC   Q9NA00;
DT   01-OCT-2000, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2000, sequence version 1.
DT   19-MAR-2014, entry version 63.
DE   SubName: Full=Wee1-like CDK tyrosine kinase;
DE   Flags: Fragment;
GN   Name=wee1-like CDK tyrosine kinase;
OS   Daphnia magna.
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Branchiopoda;
OC   Diplostraca; Cladocera; Anomopoda; Daphniidae; Daphnia.
OX   NCBI_TaxID=35525;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RA   Richards J.R., Cryer J., Kille P.;
RT   "Isolation of genes from Daphnia magna.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ292557; CAB99477.1; -; mRNA.
DR   ProteinModelPortal; Q9NA00; -.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0007067; P:mitosis; IEA:InterPro.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:GOC.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR017164; Wee1-like_protein_kinase.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF037281; Wee1-like_protein_kinase; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Kinase; Nucleotide-binding;
KW   Serine/threonine-protein kinase; Transferase.
FT   NP_BIND     218    226       ATP (By similarity).
FT   ACT_SITE    339    339       Proton acceptor (By similarity).
FT   BINDING     241    241       ATP (By similarity).
FT   NON_TER     494    494
SQ   SEQUENCE   494 AA;  55301 MW;  BC10BC034E593178 CRC64;
     MDRDIEMEEN HCRIAQRLEF PLSDEEDLHE ASTGNNRTSS NSSSDRLDSS GSDEGLGMTI
     RITSPRKPRF IRSRAREPMS PPYSGVRALR LFDSPATPKT LLENSSAIMT PVLATPAPRN
     RMRTLFTMSS TKSSDKKDNM NTPPAANVNP FTPTGMLLTS KKRTRSKRSL NGSLVNSFDE
     EVHEATDESD EEMPPKRIAL HQTSVPRYHK EFHEICLIGK GEFGSVHKCL NRLDGCTYAV
     KKSLMPVAGS PNERSALNEV WAHAVLGQHP HAVRYYSAWA ENGHMIIQNE FCNSGTLEEL
     IRTNQLNNVT VNEPQLKSTL LQIAEGLHYI HSKQLAHMDI KPGNIFICRE NSDDCSVHHD
     SDDGFDELDD DYGSVTYKIG DLGHVTSVVQ PIVEEGDCRY LPVEILRENY EHLTKADIFS
     LGLTIYEMAG GGQLPKNGDE WHAIRQGRLP YNGRYSIELH NLLELMIHPD PTLRPSTQVL
     TQHPVLGPNG AKSK
//
ID   Q91356_COTCO            Unreviewed;       367 AA.
AC   Q91356;
DT   01-NOV-1996, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1996, sequence version 1.
DT   19-FEB-2014, entry version 76.
DE   SubName: Full=Endothelial kinase Quek2;
DE   Flags: Fragment;
GN   Name=endothelial kinase Quek2;
OS   Coturnix coturnix (Common quail) (Tetrao coturnix).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Testudines + Archosauria group; Archosauria; Dinosauria; Saurischia;
OC   Theropoda; Coelurosauria; Aves; Neognathae; Galliformes; Phasianidae;
OC   Perdicinae; Coturnix.
OX   NCBI_TaxID=9091;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=8396413; DOI=10.1016/0925-4773(93)90096-G;
RA   Eichmann A., Marcelle C., Breant C., Le Douarin N.M.;
RT   "Two molecules related to the VEGF receptor are expressed in early
RT   endothelial cells during avian embryonic development.";
RL   Mech. Dev. 42:33-48(1993).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S65207; AAB28128.1; -; mRNA.
DR   PIR; B56598; B56598.
DR   ProteinModelPortal; Q91356; -.
DR   HOVERGEN; HBG080796; -.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005021; F:vascular endothelial growth factor-activated receptor activity; IEA:InterPro.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IEA:GOC.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0038084; P:vascular endothelial growth factor signaling pathway; IEA:GOC.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR009137; VEGFR3_rcpt.
DR   PANTHER; PTHR24416:SF49; PTHR24416:SF49; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   2: Evidence at transcript level;
KW   Kinase; Transferase.
FT   NON_TER     367    367
SQ   SEQUENCE   367 AA;  41793 MW;  04442B35940027A0 CRC64;
     WMDLWQSPLT MEDLICYSFQ VARGMEFLAS RKCIHRDLAA RNILLSENNV VKICDFGLAR
     DIYKDPDYVR KGSARLPLKW MAPESIFDKV YTTQSDVWSL GVLLWEIFSL GASPYPGVQI
     NEEFCQRFKD GTRMRAPEYT TAEIYRIMLS CWHGDPKERP TFSDLVEILG NLLQENVQQE
     GKDYIPLNDS HSSEDDGFSQ VPSSAQQNSD EEDFDMRIRC HSLAARYYNC VSFPGCLTGG
     NQIRCSSRIK TFEEFPMTHT MYKAHPDNQT DSGMVLASEE FERIENRHRK EGGFSSKGPN
     RTAELSAEQS DLRGRCRPSY GSQVGGQTFY NSEYGELSEH SEDRSCTPPA EGASPPALHA
     SFFSEQY
//
ID   Q9PU23_TRASC            Unreviewed;       216 AA.
AC   Q9PU23;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   16-OCT-2013, entry version 60.
DE   RecName: Full=Pyruvate kinase;
DE            EC=2.7.1.40;
DE   Flags: Fragment;
GN   Name=pyruvate kinase;
OS   Trachemys scripta elegans.
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Testudines + Archosauria group; Testudines; Cryptodira; Testudinoidea;
OC   Emydidae; Trachemys.
OX   NCBI_TaxID=31138;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=10555283;
RA   Hughes S., Zelus D., Mouchiroud D.;
RT   "Warm-blooded isochore structure in Nile crocodile and turtle.";
RL   Mol. Biol. Evol. 16:1521-1527(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RA   Hughes S.N.;
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + pyruvate = ADP + phosphoenolpyruvate.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ243136; CAB61266.1; -; mRNA.
DR   ProteinModelPortal; Q9PU23; -.
DR   HOVERGEN; HBG000941; -.
DR   UniPathway; UPA00109; UER00188.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006096; P:glycolysis; IEA:UniProtKB-UniPathway.
DR   Gene3D; 2.40.33.10; -; 1.
DR   Gene3D; 3.20.20.60; -; 1.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   InterPro; IPR015806; Pyrv_Knase_insert_dom.
DR   PANTHER; PTHR11817; PTHR11817; 1.
DR   Pfam; PF00224; PK; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF50800; SSF50800; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   TIGRFAMs; TIGR01064; pyruv_kin; 1.
PE   2: Evidence at transcript level;
KW   Glycolysis; Kinase; Magnesium; Pyruvate; Transferase.
FT   NON_TER       1      1
FT   NON_TER     216    216
SQ   SEQUENCE   216 AA;  23513 MW;  7E8F42877545B562 CRC64;
     KGSGTAEVEL KKGATLKVTL DNAFMEKCDE NVLWLDYKNL PNVVDVGSKI YIDDGLISLQ
     VKGKGADYVL TEVENGGMLG SKKGVNLPGA AVDLPAVSEK DIQDLKFGVE QDVDMVFASF
     IRKAADVHAV RQVLGEKGKX IKIISEIENH EGVRRFDEVL EASDGIMVAR GDLGIEIPAE
     KVFLAQKMMI GRCNRAGKPI ICATQMLESM IKKPRP
//
ID   Q90WS6_9SAUR            Unreviewed;       215 AA.
AC   Q90WS6;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   16-OCT-2013, entry version 58.
DE   RecName: Full=Pyruvate kinase;
DE            EC=2.7.1.40;
DE   Flags: Fragment;
GN   Name=pyruvate kinase;
OS   Elaphe sp.
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata;
OC   Toxicofera; Serpentes; Colubroidea; Colubridae; Colubrinae; Elaphe.
OX   NCBI_TaxID=114965;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RA   Hughes S.N.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver;
RA   Hughes S., Laurin M., Gouy M., Mouchiroud D.;
RT   "The phylogenetic position of turtles among sauropsidae remains
RT   contentious with new nuclear data.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + pyruvate = ADP + phosphoenolpyruvate.
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 5/5.
CC   -!- SIMILARITY: Belongs to the pyruvate kinase family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ286864; CAC69539.1; -; mRNA.
DR   ProteinModelPortal; Q90WS6; -.
DR   HOVERGEN; HBG000941; -.
DR   UniPathway; UPA00109; UER00188.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0030955; F:potassium ion binding; IEA:InterPro.
DR   GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006096; P:glycolysis; IEA:UniProtKB-UniPathway.
DR   Gene3D; 2.40.33.10; -; 1.
DR   Gene3D; 3.20.20.60; -; 1.
DR   InterPro; IPR001697; Pyr_Knase.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR011037; Pyrv_Knase-like_insert_dom.
DR   InterPro; IPR018209; Pyrv_Knase_AS.
DR   InterPro; IPR015793; Pyrv_Knase_brl.
DR   InterPro; IPR015806; Pyrv_Knase_insert_dom.
DR   PANTHER; PTHR11817; PTHR11817; 1.
DR   Pfam; PF00224; PK; 1.
DR   PRINTS; PR01050; PYRUVTKNASE.
DR   SUPFAM; SSF50800; SSF50800; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   PROSITE; PS00110; PYRUVATE_KINASE; 1.
PE   2: Evidence at transcript level;
KW   Glycolysis; Kinase; Magnesium; Pyruvate; Transferase.
FT   NON_TER       1      1
FT   NON_TER     215    215
SQ   SEQUENCE   215 AA;  23520 MW;  50FED93ADFDA0C15 CRC64;
     KGSGTAEVEL KKGATLKVTL DNAYMEKCDE HVLWVDYKNI IKVVEIGSKI YVDDGLISLK
     VKEKGADFIM TEIENGGLLG SKKGVNLPGA AVDLPAVPEK DIQDLKFGVE QDVDMVLASF
     IRKAADVHAV RKVLGEKGKN IKIISKIENH EGVRRFDEIM EASDGIMVAR GDLGIEIPAE
     KVFLAQKMMI GRCNRAGKPI ICATQMLESM IKKPP
//
